Dynamic Technology Lab Private Ltd Takes Position in Integer Holdings Corporation $ITGR

Key Points

• Dynamic Technology Lab Private Ltd has invested approximately $916,000 in Integer Holdings Corporation by acquiring 7,760 shares.
• Integer Holdings Corporation reported a 2Q earnings of $1.55 per share, missing estimates by $0.02, but achieved a revenue of $476 million, exceeding expectations.
• The stock has received multiple upgrades from analysts, with a consensus price target of $140.25, reflecting strong investment interest and potential future growth.

Dynamic Technology Lab Private Ltd bought a new stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,760 shares of the medical equipment provider's stock, valued at approximately $916,000.

Other large investors have also modified their holdings of the company. Russell Investments Group Ltd. raised its stake in shares of Integer by 14.7% in the first quarter. Russell Investments Group Ltd. now owns 6,749 shares of the medical equipment provider's stock valued at $796,000 after purchasing an additional 863 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Integer in the fourth quarter valued at $208,000. Teacher Retirement System of Texas acquired a new position in shares of Integer in the first quarter valued at $579,000. Quantbot Technologies LP acquired a new position in shares of Integer in the first quarter valued at $193,000. Finally, MQS Management LLC acquired a new position in shares of Integer in the first quarter valued at $272,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Price Performance

Shares of ITGR stock traded down $2.70 during trading hours on Friday, hitting $101.53. 396,487 shares of the company's stock were exchanged, compared to its average volume of 465,812. The stock's 50-day moving average is $109.92 and its 200-day moving average is $116.14. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18. The stock has a market cap of $3.56 billion, a price-to-earnings ratio of 44.73, a price-to-earnings-growth ratio of 0.81 and a beta of 1.03. Integer Holdings Corporation has a 52 week low of $100.89 and a 52 week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.02). The business had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.Integer's revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, research analysts forecast that Integer Holdings Corporation will post 6.01 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Wells Fargo & Company cut their target price on Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a research note on Friday, July 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and upped their price target for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Truist Financial lowered their price target on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research report on Friday, July 25th. Wall Street Zen upgraded Integer from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. Finally, Raymond James Financial lowered their price target on Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research report on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $140.25.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.